ARS Pharmaceuticals, Inc. SPRY Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s investment purchases?
- ARS Pharmaceuticals, Inc. (SPRY) reported investment purchases of $14.71M in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s investment purchases changed year-over-year?
- ARS Pharmaceuticals, Inc.'s investment purchases decreased by 57.2% year-over-year, from $34.35M to $14.71M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.